FDA 510(k)

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)

N.º K: K182387 · 2018-12-17

Fecha de decisión2018-12-17

Código de productoFMF

Comité asesorHO

DecisiónSubstantially Equivalent

Resumen del dispositivo

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) is the device name listed in this FDA 510(k) record. The listed applicant is Novo Nordisk, Inc.. It received FDA 510(k) clearance on 2018-12-17 under 510(k) number K182387. The device is classified under product code FMF. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)?

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) is a medical device that received FDA 510(k) clearance on 2018-12-17. The listed applicant is Novo Nordisk, Inc.. The 510(k) number is K182387.

When did NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) receive FDA 510(k) clearance?

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) received FDA 510(k) clearance on 2018-12-17, under 510(k) number K182387.

Who is the listed applicant for NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)?

The FDA 510(k) record lists Novo Nordisk, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)?

The FDA product code for NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) is FMF.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Novo Nordisk, Inc. como solicitante

K231255NovoFine® Plus K210258NovoFine K202005NovoFine Plus 32G Tip x 4 mm K173479NovoFine 32G Tip (0.23/0.25) x 6 mm ETW (extra thin wall)K162602NovoPen Echo

Dispositivos relacionados (Código: FMF)

K262581GraftGun Universal Graft Delivery System (GDS®)SurGenTec, LLC K252184SOL-M Luer Lock Syringe with Exchangeable Needle TraySol-Millennium Medical, Inc.K253747Disposable Pen Injector (KXYC-03C02, KXYC-03A03)Jiangsu Enjosim Medical Technology Co., Ltd.K260208Ultra-Fine™ SAFETY Insulin Syringeembecta Medical II, LLC K253110Sol-Glide Safety Needle; Sol-Glide Safety Needle with SyringeSol-Millennium Medical, Inc.K260514Profoject™ Safety Needle; Profoject™ Syringe with Safety Needle; Profoject™ Low Dead Space Syringe with Safety NeedleCMT Health PTE., Ltd.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.